References
Ntolkeras G, Barba C, Mavropoulos A, Vasileiadis GK, Dardiotis E, Sakkas LI, et al. On the immunoregulatory role of statins in multiple sclerosis: the effects on Th17 cells. Immunol Res. 2019:1–15. https://doi.org/10.1007/s12026-019-09089-5.
Koch CA, Krabbe S, Hehmke B. Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties? Rev Endocr Metab Disord. 2018;19(4):363–95. https://doi.org/10.1007/s11154-018-9478-8 Review. Erratum in: Rev Endocr Metab Disord 2019 Jun;20(2):251-252.
Zeiser R. Immune modulatory effects of statins. Immunology. 2018;154(1):69–75.
Koch CA, Antonelli A. Immunoendocrinology: when (neuro)endocrinology and immunology meet. Rev Endocr Metab Disord. 2018;19(4):277–82.
Borba VV, Zandman-Goddard G, Shoenfeld Y. Prolactin and autoimmunity: the hormone as an inflammatory cytokine. Best Pract Res Clin Endocrinol Metab. 2019;11:101324. https://doi.org/10.1016/j.beem.2019.101324.
Jara LJ, Medina G, Saavedra MA, Vera-Lastra O, Torres-Aguilar H, Navarro C, et al. Prolactin has a pathogenic role in systemic lupus erythematosus. Immunol Res. 2017;65(2):512–23.
Karpouzas GA, Ormseth SR, Hernandez E, Budoff MJ. Impact of cumulative inflammation, cardiac risk factors and medication exposure on coronary atherosclerosis progression in rheumatoid arthritis. Arthritis Rheum. 2019. https://doi.org/10.1002/art.41122.
Kitas GD, Nightingale P, Armitage J, Sattar N, Belch JJF. Symmons DPM; TRACE RA Consortium. A Mmulticenter, Rrandomized, Pplacebo-Ccontrolled Ttrial of Aatorvastatin for the Pprimary Pprevention of Ccardiovascular Eevents in Ppatients Wwith Rrheumatoid Aarthritis. Arthritis Rheum. 2019;71(9):1437–49.
Soulaidopoulos S, Nikiphorou E, Dimitroulas T, Kitas GD. The role of statins in disease modification and cardiovascular risk in rheumatoid arthritis. Front Med (Lausanne). 2018;5:24.
Li GM, Zhao J, Li B, Zhang XF, Ma JX, Ma XL, et al. The anti-inflammatory effects of statins on patients with rheumatoid arthritis: a systemic review and meta-analysis of 15 randomized controlled trials. Autoimmun Rev. 2018 Mar;17(3):215–25.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Koch, C.A., Krabbe, S. & Hehmke, B. Effect of atorvastatin on rheumatoid arthritis–associated autoreactive T cells. Immunol Res 67, 297–300 (2019). https://doi.org/10.1007/s12026-019-09105-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12026-019-09105-8